Oral Ifetroban
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Cumberland Pharmaceuticals
Overview
Oral Ifetroban is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Oral Ifetroban clinical trials
Explore related
Medical disclaimer. This page summarizes research about Oral Ifetroban for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.